Globus Medical, Inc. (BMV:GMED)

Globus Medical Statistics

Total Valuation

Globus Medical has a market cap or net worth of MXN 151.39 billion. The enterprise value is 149.38 billion.

Market Cap	151.39B
Enterprise Value	149.38B

Important Dates

The next estimated earnings date is Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	112.63M
Shares Outstanding	n/a
Shares Change (YoY)	+4.89%
Shares Change (QoQ)	-2.34%
Owned by Insiders (%)	17.07%
Owned by Institutions (%)	86.89%
Float	111.74M

Valuation Ratios

The trailing PE ratio is 22.51 and the forward PE ratio is 17.43.

PE Ratio	22.51
Forward PE	17.43
PS Ratio	3.06
PB Ratio	1.87
P/TBV Ratio	3.89
P/FCF Ratio	15.22
P/OCF Ratio	12.00
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.63, with an EV/FCF ratio of 15.02.

EV / Earnings	22.21
EV / Sales	3.06
EV / EBITDA	10.63
EV / EBIT	17.35
EV / FCF	15.02

Financial Position

The company has a current ratio of 4.07, with a Debt / Equity ratio of 0.03.

Current Ratio	4.07
Quick Ratio	2.09
Debt / Equity	0.03
Debt / EBITDA	0.16
Debt / FCF	0.23
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 8.62% and return on invested capital (ROIC) is 6.50%.

Return on Equity (ROE)	8.62%
Return on Assets (ROA)	5.82%
Return on Invested Capital (ROIC)	6.50%
Return on Capital Employed (ROCE)	10.22%
Revenue Per Employee	9.35M
Profits Per Employee	1.27M
Employee Count	5,300
Asset Turnover	0.53
Inventory Turnover	1.12

Taxes

In the past 12 months, Globus Medical has paid 318.53 million in taxes.

Income Tax	318.53M
Effective Tax Rate	4.52%

Stock Price Statistics

The stock price has decreased by -20.43% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-20.43%
50-Day Moving Average	1,352.47
200-Day Moving Average	n/a
Relative Strength Index (RSI)	42.93
Average Volume (20 Days)	851

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.77

Income Statement

In the last 12 months, Globus Medical had revenue of MXN 49.53 billion and earned 6.73 billion in profits. Earnings per share was 48.53.

Revenue	49.53B
Gross Profit	33.24B
Operating Income	8.75B
Pretax Income	7.04B
Net Income	6.73B
EBITDA	13.87B
EBIT	8.75B
Earnings Per Share (EPS)	48.53

Balance Sheet

The company has 4.33 billion in cash and 2.29 billion in debt, giving a net cash position of 2.04 billion.

Cash & Cash Equivalents	4.33B
Total Debt	2.29B
Net Cash	2.04B
Net Cash Per Share	n/a
Equity (Book Value)	81.01B
Book Value Per Share	599.84
Working Capital	24.61B

Cash Flow

In the last 12 months, operating cash flow was 12.62 billion and capital expenditures -2.67 billion, giving a free cash flow of 9.95 billion.

Operating Cash Flow	12.62B
Capital Expenditures	-2.67B
Free Cash Flow	9.95B
FCF Per Share	n/a

Margins

Gross margin is 67.10%, with operating and profit margins of 17.66% and 13.58%.

Gross Margin	67.10%
Operating Margin	17.66%
Pretax Margin	14.22%
Profit Margin	13.58%
EBITDA Margin	28.00%
EBIT Margin	17.66%
FCF Margin	20.08%

Dividends & Yields

Globus Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.89%
Shareholder Yield	-4.89%
Earnings Yield	4.44%
FCF Yield	6.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Globus Medical has an Altman Z-Score of 10.59 and a Piotroski F-Score of 5.

Altman Z-Score	10.59
Piotroski F-Score	5